XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Unaudited - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (1,534,081) $ (408,105)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 26,621 5,447
Amortization of insurance premium 7,184 0
Non-cash operating lease cost 8,629  
Stock-based compensation 366,200 3,257
Loss on disposal of property and equipment 56 139
Change in fair value of contingent forward contract liability 454,546 8,719
Change in fair value of convertible preferred stock warrant liability   200
Changes in operating assets and liabilities:    
Accounts receivable (1) (163)
Inventory (60,112) (1,863)
Financed insurance premium (41,935) 0
Prepaid expenses (23,762) 9,556
Other current assets 8,299 3,254
Other noncurrent assets and security deposit (5,861) (9,324)
Accounts payable (14,175) (30,109)
Accrued compensation 12,752 8,880
Operating lease liability (4,516)  
Other liabilities and accrued liabilities 17,834 22,732
Other long-term liabilities 5,158 10,002
Net cash used in operating activities (745,401) (377,407)
Cash flows from investing activities:    
Purchases of property, equipment, and software (299,313) (355,860)
Proceed from sale of property, equipment, and software 19 0
Net cash used in investing activities (299,294) (355,860)
Cash flows from financing activities:    
Payment for short-term insurance financing note (16,819) 0
Payment for capital lease liabilities   (174)
Payment for finance lease liabilities (1,915)  
Proceeds from short-term insurance financing note 41,935 0
Proceeds from exercise of stock options 6,027 2,886
Proceeds from the exercise of public warrants 173,273 0
Proceeds from the reverse recapitalization 4,439,153 0
Payment of transaction costs related to the reverse recapitalization (4,811) 0
Net cash provided by financing activities 5,236,843 892,575
Net increase in cash, cash equivalents, and restricted cash 4,192,148 159,308
Beginning cash, cash equivalents, and restricted cash 640,418 379,651
Ending cash, cash equivalents, and restricted cash 4,832,566 538,959
Supplemental disclosure of cash flow information:    
Cash paid for interest 324 21
Supplemental disclosure of non-cash investing and financing activity:    
Property and equipment included in accounts payable and accrued expense 5,756 81,011
Leased assets obtained in exchange for new finance lease liabilities 70,756  
Issuance of Series D convertible preferred stock upon exercise of preferred stock warrants 9,936  
Issuance of Series E convertible preferred stock contingent forward contracts 2,167,332 793
Capital contribution upon forfeit of Series E awards 15,719 0
Issuance of common stock upon conversion of preferred stock in connection with the reverse recapitalization 5,836,785 0
Transaction costs related to the reverse recapitalization not yet paid 34,054 0
Convertible Preferred Stock Warrant Liability    
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of convertible preferred stock warrant liability 6,976 171
Common Stock Warrant Liability    
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of convertible preferred stock warrant liability 24,787 0
Series B    
Cash flows from financing activities:    
Payments for repurchase of convertible preferred stock (3,000) 0
Series C    
Cash flows from financing activities:    
Payments for repurchase of convertible preferred stock 0 (9,861)
Series D    
Cash flows from financing activities:    
Proceeds from issuance of convertible preferred shares 3,000 400,000
Supplemental disclosure of non-cash investing and financing activity:    
Issuance of Series D convertible preferred stock upon settlement of contingent forward contracts   39,563
Series E    
Cash flows from financing activities:    
Proceeds from issuance of convertible preferred shares 600,000 499,724
Supplemental disclosure of non-cash investing and financing activity:    
Issuance of Series E convertible preferred stock upon settlement of contingent forward contracts $ 2,621,878 $ 0